Publications » 2010

Show per page  
Conferences
11Liepina I.; Zemitis A.; Duburs G.; Czaplewsky C.; Liwo A. Artifical lipid and its binding with DNA. Abstract Book Cell Penetrating Peptides, 31st European Peptide Symposium CPP satellite meeting ; September 10-11: Copenhagen, 2010.      

12Lapidus D. ; Ventura S.; Czaplewsky C.; Liwo A.; Liepina I. Molecular dynamics of Amyloid single beta-sheet. Tēzes = Abstracts, 8. Latvijas matemātikas konference = 8th Latvian mathemātical conference; April 9-10: Valmiera, Latvia, 2010; 43.      

13Duka V.; Bestel I.; Czaplewsky C.; Liwo A.; Liepina I. Molecular modeling of a single beta-sheet of Amyloid B-protein (Abeta) 25-35. Tēzes = Abstracts, 8. Latvijas matemātikas konference = 8th Latvian mathemātical conference ; April 9-10: Valmiera, Latvia, 2010; 27.      

14Svalbe B.; Muceniece R.; Vavers E.; Liepinsh E.; Zvejniece L. The antihypnotic and anrihypoxic effects of Mildronate. In Focused Conference Group: P14 - Addition and doping: Neurobiological and clinical . Final Programme , WorldPharma2010. 16th World Congress on Basic and Clinical Pharmacology; 17-23 July: Copenhagen, Denmark. Paper No 1699, 2010; 598.      

15Skapare E.; Liepinsh E.; Svalbe B.; Dambrova M. Cardioprotective drug Mildronate enhances the anti-diabetic activity of metformin in obese zucker rats. In Focused Conference Group: P05 - Translational sience in the metabolic syndrome: basic and clinical pharmacology . Final Programme, WorldPharma2010. 16th World Congress on Basic and Clinical Pharmacology; 17-23 July: Copenhagen, Denmark. Paper No 674, 2010; 583.      

16Klusa V.; Pupure J.; Isajevs S.; Svirina D.; Beitnere U.; Jansone B.; Rumaks J.; Svirskis S.; Vilskersts R.; Kalvinsh I. Neuroprotective effect of Mildronate, a mitochondria-targeted drug, in Parkinson,s disease model in rats. In Focused Conference Group: PW19 - Influence of degeneration and repair in the CNS and periphery. Final Programme, WorldPharma2010. 16th World Congress on Basic and Clinical Pharmacology; 17-23 July: Copenhagen, Denmark. Paper No 1746, 2010; 381.      

17Dzirkale Z.; Pupure J.; Rumaks J.; Vanina M.; Svirskis S.; Mezhapuke R.; Fernandes M.A.; Duburs G.; Muceniece R.; Klusa V. Taurine and its analogue tauropyrone: comparative pharmacological activities. In Focused Conference Group: P11-G. Protein-coupled 7TM receptors: from molecular to physiological function . Final Programme, WorldPharma2010. 16th World Congress on Basic and Clinical Pharmacology; 17-23 July: Copenhagen, Denmark. Paper No 1747, 2010; 263.      

18Svalbe B.; Muceniece R.; Liepinsh E.; Dambrova M.; Zvejniece L. L-Carnitine regulator - mildronate exerts acute anticinvulsant and antihypnotic effects. Abstracts, 35th FEBS Congress Molecules of Life; June 25 - July 1: Gothenburg, Sweden. The FEBS Journal, Vol.277, Suppl. 1, A4.10, 2010; 79.      

19Zvejniece L.; Svalbe B.; Dambrova M. Antihypoxic action of an inhibitor of L-carnitine biosynthesis. Meeting of the COST Action TD0901 Oxygen in Health and Disease; June 15-18: Smolenice Castle, Slovakia, 2010; 65.      

20Kuka J.; Vilskersts R.; Vavers E.; Liepins E.; Dambrova M. Effects of regulation of L-carnitine concentration in experimental heart infarction model. Final Programme and Abstract Book, Frontiers in Cardiovascular Biology; First Congress of the European Society of Cardiology Council on Basic Cardiovascular Science; Berlin, 16-19 July: Cardiovascular Res., Vol.87, Suppl.1. Oxford Journals, 2010; 509.      

Show per page